Inspire Corporate Bond ETF (IBD)
ARCA ARCA Primary 
IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
Catalyst struck a deal Wednesday with Teva that will prevent the generic drugmaker from knocking off Firdapse until 2035. The post IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva appeared first on Investor's Business Daily.
Carpenter Technology Stock Receives IBD Stock Rating Upgrade
Carpenter Technology saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 94 the day before. The post Carpenter Technology Stock Receives IBD Stock Rating Upgrade appeared first on Investor's Business Daily.
IBD Sector Leader Breaks Out On First China Policy Shift In 14 Years
Sector leader Atour Lifestyle has been riding the China stimulus wave as it hovers near a buy point and all-time high. The post IBD Sector Leader Breaks Out On First China Policy Shift In 14 Years appeared first on Investor's Business Daily.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points
Meta stock and Nvidia peer Broadcom are among among five S&P 500 stocks on IBD Leaderboard that are near buy points. The post Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points appeared first on Investor's Business Daily.
Spyre: Extended Half-Life Tech To Become Differentiating Factor For IBD Targeting
Spyre Therapeutics, Inc. interim data from the phase 1 study, using SPY001 in healthy volunteers, is expected by the end of 2024. SPY001 is an a4b7 inhibitor being developed to target IBD like Crohn's Disease and Ulcerative Colitis. The Crohn's Disease treatment market is projected to reach a value of $17.80 billion by 2033.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Making its debut on 07/10/2017, smart beta exchange traded fund Inspire Corporate Bond ETF (IBD) provides investors broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Eli Lilly acquires IBD drug developer Morphic in $3.2bn deal
Eli Lilly and Co (NYSE:LLY) has struck a deal to acquire Morphic Holding Inc (NASDAQ:MORF), a maker of inflammatory bowel disease (IBD) drugs, for approximately $3.2 billion. On a per-share basis the deal is priced at $57, to be paid in cash.
Cream of the Crop Part III: 3 (More) Must-Buy Stocks From IBD's Top 50
As I've noted in a few past columns, “Investor's Business Daily's IBD 50 is ‘a weekly, rules-based, computer-generated stock index.'” Moreover, the stocks on the list tend to be fundamentally strong and have top-notch growth outlooks.
Best Growth Stocks To Buy And Watch: See Updates To IBD Watchlists
Where can you find the best growth stocks to buy and watch? Start by checking the IBD 50, IBD Sector Leaders, IBD Big Cap 20, IPO Leaders and Stock Spotlight. You'll also find stocks like Microsoft (MSFT), ServiceNow (NOW) and PayPal (PYPL) whose track records of stable earnings growth have earned them a spot on IBD Long-Term Leaders. Be sure to check this page each day to see which stocks have just been added or removed from those screens. IBD stock lists, which have a history of beating the S&P 500, are based on our proprietary CAN SLIM Investing System, which helps identify today's most promising growth stocks by identifying those that are displaying the same traits that the best-performing stocks typically show in the early stages of a big move. But never buy a stock simply because it's on one of IBD's screens. Always do your own research and run all the stocks you're tracking through a buying checklist. And you can also use IBD's simple three-step routine to stay in sync with market conditions and make sure you have today's best growth stocks on your radar. Get Timely Buy And Sell Alerts With Leaderboard YOU MIGHT ALSO LIKE: Join IBD Live And Learn Top Chart-Reading And Trading Techniques From The Pros Looking For The Next Breakout Stocks? Start Here Which Companies Are Now Outperforming 95% Of All Stocks? Want Weekly Tips On Investing? Get The 'How To Invest' Newsletter How To Buy Stocks | Buying Checklist When To Sell Stocks | Selling Checklist
Cryptocurrency Prices And News: Ethereum Spikes On ETF Approval Chatter
Cryptocurrency News: Cryptocurrency prices leapt Monday after Bloomberg increased its odds that the Securities and Exchange Commission will approve spot ethereum ETFs. Elsewhere, bitcoin spiked back to $70,000 and could test its record highs this week, one analyst says. Bloomberg ETF analysts Eric Balchunas and James Seyffart on Monday increased their odds that the SEC will approve VanEck's spot ethereum application to 75% from 25%. Nine issuers, including VanEck and ARK Investment Management, have filed with the SEC to list spot bitcoin ETFs. The SEC will approve or deny the first round 19b-4s this week, with votes on VanEck and ARK's filings on Wednesday and Thursday, respectively. The 19b-4 forms and S-1 registration statements must both be approved for ETFs to launch. "Hearing chatter this afternoon that SEC could be doing a 180 on this (increasingly political issue)," Balchunas posted on social media platform X. "So now everyone scrambling (like us everyone else assumed they'd be denied). "We also need S-1 approvals," Seyffart said online. He noted that it could be weeks to months before S-1 filings are actually approved. "That said, if we're correct and see these theoretical approvals later this week. It should mean that S-1 approvals are a matter of 'when' not 'if'," Seyffart added. Bitcoin on April 19 completed its fourth halving event, which slashed the rewards doled out to miners. Bitcoin's price has historically risen in the months following previous halvings, but analysts are divided on the impact this year's event will have. Elsewhere, Sam Bankman-Fried on March 28 was sentenced to 25 years in prison for his role in the 2022 collapse of crypto exchange FTX. The strong of new highs is rooted in the industry's historic step forward on Jan. 11. That was the first trading day after the SEC approved 11 bitcoin ETF applications, which included issuers ARK Invest (ARKK), BlackRock (BLK), Grayscale, VanEck and more. Coinbase serves as the custodian for a majority of the new ETF issuers. How are crypto custodians keeping digital assets secure? The Best Bitcoin, Cryptocurrency ETFs To Watch And Buy Click here to jump to more on today's Cryptocurrency News. Bitcoin on Monday jumped to $69,500, marking a 5% gain over the last 24 hours. Bitcoin peaked at $70,399 intraday Monday before easing. On March 14 bitcoin hit a new all-time high of $73,798. The cryptocurrency is below its prior peak of $68,990 set in November 2021. Bitcoin had spiked to $49,000 January 11 on the ETF launch day but then fell back into its early December 2023 level prior to the SEC announcement. The world's largest cryptocurrency rebounded about 157% in 2023. Bitcoin is now up about 65% so far this year. Ethereum spiked to $3,500 late Monday, rallying nearly 14% over the last 24 hours. Ethereum is trending back toward its March 12, 52-week high of $4,092. The No. 2 crypto well below its November 2021 peak above $4,800. Ethereum on March 8 crossed its $4,000 level for the first time in 26 months. Still, ETH soared 53% in 2024. Scroll down for more cryptocurrency news and price updates. Digital asset investments are extremely volatile. While cryptocurrency's fundamentals and technical indicators may differ, investors should focus on the same key objectives. First, stay protected by learning when it's time to sell, cut losses or capture profits. Second, prepare to profit if the cryptocurrency starts to rebound. Despite their original promise, cryptocurrencies haven't acted as hedges against inflation. Instead, they've trended with the broader indexes. Read The Big Picture and Market Pulse to track daily market trends. View IBD's Best Cryptocurrencies And Crypto Stocks To Buy And Watch page to help navigate the world of digital asset investments. Want a deeper dive into crypto? Check out the What Is Cryptocurrency? explainer page. How Bitcoin's Upcoming Halving Differs From The Crypto's Previous Cycles European Central Bank Cranks Up Bitcoin Criticism You Say Bitcoin Is Digital Gold? Maybe It's Digital Pearls Want market-driving info delivered straight to your inbox? Sign up for IBD's new daily newsletter by clicking the image below. YOU MIGHT ALSO LIKE: Get Stock Lists, Stock Ratings And More With IBD Digital Find Stocks To Buy And Watch With IBD Leaderboard Identify Bases And Buy Points With MarketSmith Pattern Recognition Use Swing Trading Strategies To Find Opportunities & Manage Risk
